Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shot up 16.7% on Monday . The stock traded as high as GBX 20 ($0.25) and last traded at GBX 17.50 ($0.22). 27,811 shares were traded during trading, a decline of 64% from the average session volume of 77,314 shares. The stock had previously closed at GBX 15 ($0.19).
Celadon Pharmaceuticals Trading Up 14.3 %
The stock has a 50 day simple moving average of GBX 21.48 and a 200-day simple moving average of GBX 40.50. The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 194.82. The firm has a market cap of £13.77 million, a P/E ratio of -250.00 and a beta of -0.26.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Stories
- Five stocks we like better than Celadon Pharmaceuticals
- Earnings Per Share Calculator: How to Calculate EPS
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- The How and Why of Investing in Gold Stocks
- 2 Drone Stocks Surging from Increased Media Attention
- What is a Low P/E Ratio and What Does it Tell Investors?
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
